Paul Whitfield is The Deal’s international mining and energy correspondent based in Paris, where he also covers international M&A across Europe, Australia and Asia. Whitfield has written extensively on the oil sector as well as the nuclear industry and the rise of China as a driver of commodity deals. Prior to joining The Deal, Whitfield had written on finance and investment for a number of British national newspapers including The Independent, Daily Telegraph and Financial Times, as well as the BBC. He has also worked as a financial journalist for BBC’s daily business show, “Working Lunch.”
The Swiss drugmaker will pay $2.1 billion for Endocyte, justifying the Nasdaq-listed biotech's pivot to prostate treatment last year.
Canada's Brookfield Property won the support of GGP after upping the cash portion of an about $15 billion cash-and-share offer for the two-thirds it doesn't already own of the U.S. mall operator.
France's Sanofi could end its long search for a biotech deal after striking an $11.6 billion offer for Massachusetts-based Bioverativ, a maker of hemophilia treatments.
Novo Nordisk's $3 billion offer for the Belgian blood disease biotech comes after the target twice refused to enter takeover talks.
Saudi Arabia's state-owned oil company will spend $414 billion over the next decade to maintain oil output and diversify into non-oil projects.
Oil prices are up, but not by much, following OPEC and Russia's well managed production cut announcement.
Thursday's OPEC-led meeting is likely to announce oil cuts will run until the end of 2018 but include an option to wind them up early.
OPEC and Russian discord means a widely expected nine-month extension to production caps remains highly uncertain, skewing oil price risk to the downside.
The maker of Remy Martin cognac's half-year results met analyst expectations but suffered by comparison to rivals' strong performance.
Tesla has finished installing the world's biggest lithium-ion battery park, beating a 100-day deadline after which Elon Musk promised to give the facility to Australia for free.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.